These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15660022)

  • 21. Inhibition of inflammatory corneal angiogenesis by TNP-470.
    Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro.
    Kanayama S; Nishida K; Yamato M; Hayashi R; Sugiyama H; Soma T; Maeda N; Okano T; Tano Y
    Exp Eye Res; 2007 Dec; 85(6):772-81. PubMed ID: 17904552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous TNFalpha suppression of neovascularization in corneal stroma in mice.
    Fujita S; Saika S; Kao WW; Fujita K; Miyamoto T; Ikeda K; Nakajima Y; Ohnishi Y
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3051-5. PubMed ID: 17591872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
    Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.
    Yao L; Pike SE; Tosato G
    J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications.
    Lavie G; Mandel M; Hazan S; Barliya T; Blank M; Grunbaum A; Meruelo D; Solomon A
    Angiogenesis; 2005; 8(1):35-42. PubMed ID: 16132616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer.
    Kay EP; Gu X; Smith RE
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2427-35. PubMed ID: 8163333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PEDF-derived peptide inhibits corneal angiogenesis by suppressing VEGF expression.
    Matsui T; Nishino Y; Maeda S; Yamagishi S
    Microvasc Res; 2012 Jul; 84(1):105-8. PubMed ID: 22386653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.
    BenEzra D; Griffin BW; Maftzir G; Aharonov O
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3601-8. PubMed ID: 8258518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhibitory effects of ampelopsin on angiogenesis].
    Luo GQ; Zeng S; Liu DY
    Zhong Yao Cai; 2006 Feb; 29(2):146-50. PubMed ID: 16617784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Suppression of corneal neovascularization by conditioned culture medium of human amniotic membrane].
    Ma X; Bazan H; Li J
    Zhonghua Yan Ke Za Zhi; 2003 Dec; 39(12):753-6. PubMed ID: 14769230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF).
    Murata M; Takanami T; Shimizu S; Kubota Y; Horiuchi S; Habano W; Ma JX; Sato S
    Curr Eye Res; 2006 Feb; 31(2):171-80. PubMed ID: 16500768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
    Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
    Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
    Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
    Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of topical infliximab on corneal neovascularization in rabbits.
    Kim JW; Chung SK
    Cornea; 2013 Feb; 32(2):185-90. PubMed ID: 23146933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
    Knighton DR; Phillips GD; Fiegel VD
    J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-angiogenic activity of inositol hexaphosphate (IP6).
    Vucenik I; Passaniti A; Vitolo MI; Tantivejkul K; Eggleton P; Shamsuddin AM
    Carcinogenesis; 2004 Nov; 25(11):2115-23. PubMed ID: 15297368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin.
    Sheu SJ; Chou LC; Bee YS; Chen JF; Lin HC; Lin PR; Lam HC; Tai MH
    Exp Eye Res; 2005 Dec; 81(6):673-9. PubMed ID: 15967435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.